PhRMA· @PhRMA · X·· 2 天前AI 评分18
AI 导读
在实验室改造细胞仅36个月后,一位患有4期黑色素瘤的三孩母亲接受了在休斯顿开发的疗法治疗。她今天还活着,这归功于生物制药创新。 在@axios Live休斯顿活动上,Rice Biotech Launchpad的Paul Wotton分享了强大创新生态系统带来的真实患者影响。https://ow.ly/itXP5106AQI
正文
Just 36 months after engineering cells in a lab, a mother of three with stage 4 melanoma was dosed with a therapy developed in Houston. She’s alive today because of biopharmaceutical innovation.
At @axios Live’s Houston event, Rice Biotech Launchpad’s Paul Wotton shared the very real patient impact of a strong innovation ecosystem. https://ow.ly/itXP5106AQI
来源:PhRMA · x.com